MktsMarkets

Chemomab Therapeutics Ltd.
NASDAQ: CMMBKey statistics
CMMB News
Stories mentioning CMMB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q4 '25Dec 31 | Q4 '24Dec 31 | Q4 '23Dec 31 | Q1 '23Mar 31 | Q4 '22Dec 31 | Q3 '22Sep 30 | Q2 '22Jun 30 | Q1 '22Mar 31 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | (2,326) | (2,465) | (4,393) | 0.00 | (5,142) | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | (9,391) | (3,897) | 3,157 | 6,887 | 5,895 | 5,423 | 2,914 | 2,745 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | (14,053) | (8,881) | 1,839 | 9,049 | 8,642 | 8,317 | 6,254 | 5,320 |
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 14,551 | 9,601 | (675.00) | (8,732) | (8,262) | (8,080) | (6,734) | (5,104) |
| Tax Provision | 523.00 | 523.00 | 523.00 | 21.00 | 10.00 | 0.00 | (544.00) | 0.00 |
| Net Income (Loss) | 14,028 | 9,078 | (1,198) | (8,753) | (8,272) | (8,080) | (6,190) | (5,104) |
| Earnings Per Share (Basic) | 0.03 | 0.03 | (0.01) | 0.04 | (0.04) | 0.04 | 0.03 | 0.02 |
| Earnings Per Share (Diluted) | 0.03 | 0.03 | (0.01) | 0.04 | (0.04) | 0.04 | 0.03 | 0.02 |
| Weighted Average Shares Outstanding (Basic) | 510,228 | 359,049 | 234,999 | 220,996 | 227,589 | 228,773 | 228,173 | 228,090 |
| Weighted Average Shares Outstanding (Diluted) | 510,228 | 359,049 | 234,999 | 220,996 | 227,589 | 228,773 | 228,173 | 228,090 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CMMB
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) is a stock listed on the Nasdaq Stock Market under the ticker symbol CMMB. It last traded at $1.55 (Nov 18, 2026, 4:00 PM ET), down 5.5% on the day. That gives Chemomab Therapeutics a market capitalisation of $11.9M.
Over the past 52 weeks CMMB has traded between $0.9200 and $2.99.
Net income for the quarter ended Dec 31, 2025 was $14.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Dec 31, 2025 | — | $14.0M |
| Dec 31, 2024 | — | $9.1M |
| Dec 31, 2023 | — | -$1.2M |
| Mar 31, 2023 | — | -$8.8M |
From Chemomab Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…